Skip to main content
SpringerLink
Log in
Book cover

Influenza Vaccines for the Future

  • Book
  • © 2011

Overview

Editors:
  1. Rino Rappuoli

    1. Novartis Vaccines & Diagnostics S.r.l., Siena, Italy

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Giuseppe Del Giudice

    1. Novartis Vaccines & Diagnostics S.r.l., Siena, Italy

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Presents new vaccination strategies in the light of the most recent outbreak
  • Presents a thorough discussion on immune response and correlates of protection
  • Provides an overview of epidemiology and the control of influenza
  • Includes supplementary material: sn.pub/extras

Part of the book series: Birkhäuser Advances in Infectious Diseases (BAID)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (19 chapters)

  1. Front Matter

    Pages i-xiv
    Download chapter PDF

  2. Evolution and Epidemiology

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Influenza Virus: The Biology of a Changing Virus

      • Samira Mubareka, Peter Palese
      Pages 3-26

    3. The Epidemiology of Influenza and Its Control

      • Lone Simonsen, Cécile Viboud, Robert J. Taylor, Mark A. Miller
      Pages 27-54

    4. Epidemiology of Influenza in Tropical and Subtropical Low-Income Regions

      • W. Abdullah Brooks, Mark C. Steinhoff
      Pages 55-75

    5. The Origin and Evolution of H1N1 Pandemic Influenza Viruses

      • Robert G. Webster, Richard J. Webby, Michael Perdue
      Pages 77-93

    6. The Emergence of 2009 H1N1 Pandemic Influenza

      • Benjamin Greenbaum, Vladimir Trifonov, Hossein Khiabanian, Arnold Levine, Raul Rabadan
      Pages 95-111

  3. Immunity and Vaccine Strategies

    1. Front Matter

      Pages 113-113
      Download chapter PDF

    2. Influenza Vaccines Have a Short but Illustrious History of Dedicated Science Enabling the Rapid Global Production of A/Swine (H1N1) Vaccine in the Current Pandemic

      • John Oxford, Anthony Gilbert, Robert Lambkin-Williams
      Pages 115-147

    3. Influenza and Influenza Vaccination in Children

      • Romina Libster, Kathryn M. Edwards
      Pages 149-171

    4. The Immune Response to Influenza A Viruses

      • Justine D. Mintern, Carole Guillonneau, Stephen J. Turner, Peter C. Doherty
      Pages 173-197

    5. Correlates of Protection Against Influenza

      • Emanuele Montomoli, Barbara Capecchi, Katja Hoschler
      Pages 199-222

    6. The Role of Animal Models In Influenza Vaccine Research

      • Catherine J. Luke, Kanta Subbarao
      Pages 223-272

    7. Live Attenuated Influenza Vaccine

      • Harry Greenberg, George Kemble
      Pages 273-291

    8. Cell Culture-Derived Influenza Vaccines

      • Philip R. Dormitzer
      Pages 293-312

    9. Conserved Internal Proteins as Potential Universal Vaccines

      • Alan Shaw
      Pages 313-325

    10. Emulsion-Based Adjuvants for Improved Influenza Vaccines

      • Derek T. O’Hagan, Theodore Tsai, Steven Reed
      Pages 327-357

    11. Lessons Learned from Clinical Trials in 1976 and 1977 of Vaccines for the Newly Emerged Swine and Russian Influenza A/H1N1 Viruses

      • Robert B. Couch
      Pages 359-371

    12. Occurrences of the Guillain–Barré Syndrome (GBS) After Vaccinations with the 1976 Swine A/H1N1 Vaccine, and Evolution of the Concern for an Influenza Vaccine-GBS Association

      • Robert B. Couch
      Pages 373-382

    13. Human Monoclonal Antibodies for Prophylaxis and Treatment of Influenza

      • Wouter Koudstaal, Fons G. UytdeHaag, Robert H. Friesen, Jaap Goudsmit
      Pages 383-398
Back to top

Keywords

About this book

The emergence of H5N1 avian influenza in 1997 and of the influenza A H1N1 of swine origin in 2009 calls for new, rapid and sustainable solutions for both seasonal and pandemic influenza viruses. During the last ten years, science and technology have made enormous progress, and we are now able to monitor in real time the genetics of viruses while they spread globally, to make more powerful vaccines using novel adjuvants, and to generate viruses in the laboratory using reverse genetics. This volume not only provides state-of-the-art information on the biology of influenza viruses and on influenza vaccines, but is also designed to be a resource to face the present H1N1 pandemic and to plan for long-term global and sustainable solutions.

Reviews

From the reviews of the second edition:

“What the book delivered was a curious juxtaposition of historical perspective alongside a modern commercial approach: from what went wrong in the swine flu vaccination incident of 1976 in the USA, to which companies are using M2 protein conjugates. … This type of information is quite hard to glean from the academic literature. It was also great to get solid information about the state of the art today … . Overall there is some useful detail in this book that is hard to get elsewhere.” (Wendy Barclay, Microbiology Today, May, 2011)

Editors and Affiliations

  • Novartis Vaccines & Diagnostics S.r.l., Siena, Italy

    Rino Rappuoli, Giuseppe Del Giudice

Bibliographic Information

  • Book Title: Influenza Vaccines for the Future

  • Editors: Rino Rappuoli, Giuseppe Del Giudice

  • Series Title: Birkhäuser Advances in Infectious Diseases

  • DOI: https://doi.org/10.1007/978-3-0346-0279-2

  • Publisher: Springer Basel

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: Springer Basel AG 2011

  • Hardcover ISBN: 978-3-0346-0278-5Published: 30 October 2010

  • Softcover ISBN: 978-3-0348-0335-9Published: 14 March 2012

  • eBook ISBN: 978-3-0346-0279-2Published: 28 October 2010

  • Series ISSN: 2504-3811

  • Series E-ISSN: 2504-3838

  • Edition Number: 2

  • Number of Pages: XIV, 446

  • Number of Illustrations: 40 b/w illustrations, 30 illustrations in colour

  • Topics: Virology, Life Sciences, general

Publish with us

Policies and ethics

Back to top

Search

Navigation